Voltage activated calcium channel blockers, pharmaceutical components containing these compounds, and the use of these compounds to treat and / or prevent pain and other diseases and / or disorders. 1. Claim 1: compound (1) of general formula,characterized in that n represents 0, 1 or 2； m represents 0 or 1 with the condition that n ³ m； X is selected from the group consisting of O, S, NH and N-C₁₋₆ alkyl；R1,R2 and R3,a. Select one person from class h, class F, class Cl, class BR, class I and class no832222 respectively；CN； C₁₋₆ alkyl；CF CF H CFH CF Cl CFClC (= O) - H； C (= O) - tar c833131；C (= O) - Oh； C (= O) - o-tar c8332131 = 832626；C (3DO) -N (H) (OH)C (3DO) -NHC(=O)N(H)(alquilo C₁₋₆)；C (3DO) -N (alquilo C)C (3DN-OH) -H C 3D (N-OH) -alquilo CC (= n-o-lessor c8321)；OH OCF OCF H OCFH OCF Cl OCFClO-c83218c831832626；O-C (3DO) -alquilo CO-C (3DO) -O-alquilo CO - (C = O) - n (H) (rent c832131； 832626)；O-C (= O) N (C₁₋₆ alkyl) ₂；O-S (= O) ₂-C₁₋₆-alkyl；O-S (= O) ₂-OH； O-S (= O) ₂-O-C₁₋₆ alkyl；O-S (3DO) -NHO-S (3DO) -N (H) (alquilo C)O-S (3DO) -N (alquilo C)NH.83222；N(H)(alquilo C₁₋₆)；N (lease No. c8332121) 833183226；Rent n (H) - C (= O) - c83218c83226；N (H) - C (= O) - o-tar c832138；N (H) -C (3DO) -NHN (H) - C (o) - n (H) (asphalt c832131；N (H) -C (3DO) -N (alquilo C)N (C₁₋₆ alkyl) -C (= O) -C₁₋₆ alkyl；N (c83218c83326) - C (= O) - o-tar c83321c8326)；N (alquilo C) -C (3DO) -NHN (alquilo C) -C (3DO) -N (H) (alquilo C)N (c83218c83318c833222) - C (= O) - n (pitch c83218c833222)；N (H) -S (3DO) OH N (H) -S (3DO) -alquilo CN(H)-S(=O)₂-O-alquilo C₁₋₆；N (H) -S (3DO) -NHN (H) -S (3DO) -N (H) (alquilo C)N (H) -S (3DO) N (alquilo C)N (alquilo C) -S (3DO) -OH N (alquilo C) -S (3DO) -alquilo CN (alquilo C) -S (3DO) -O-alquilo CN (alquilo C) -S (3DO) -NH N (alquilo C) -S (3DO) -N (H) (alquilo C)N (alquilo C) -S (3DO) -N (alquilo C)SH SCF SCF H SCFH SCF Cl SCFClS-lease c83218c31832626；S (= O) -C₁₋₆ alkyl；S (= O) 832222 - c83218c rent；S (= O) ₂-OH； S (= O) ₂-O-C₁₋₆ alkyl；S (3DO) -NHS
